InMed Pharmaceuticals Inc. (MTRI): Form 8-K filed 2026-07-22

Items reported

Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	CURRENT REPORT	ea0298644-8k425_inmed.htm
EX-10.1	AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 22, 2026, BY	ea029864401ex10-1.htm
EX-99.1	PRESS RELEASE, ISSUED ON JULY 22, 2026	ea029864401ex99-1.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.